Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001437001 | SCV001639847 | likely benign | Colorectal cancer, susceptibility to, 10 | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000664285 | SCV002626711 | likely benign | Hereditary cancer-predisposing syndrome | 2019-12-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
True Health Diagnostics | RCV000664285 | SCV000788148 | uncertain significance | Hereditary cancer-predisposing syndrome | 2017-10-25 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004544924 | SCV004761481 | likely benign | POLD1-related disorder | 2019-03-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |